Samrat Pharmachem Ltd
₹211.80
(1.36%)
Fri, 27 Mar 2026, 02:36 pm
Samrat Pharmachem Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 49.09 | 49.09 | 49.09 | 49.09 | 49.09 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 3.24 | 0 | 0 |
| Public | 50.91 | 50.91 | 47.67 | 50.91 | 50.91 |
| Government | 0 | 0 | 0 | 0 | 0 |
Samrat Pharmachem Ltd Shareholding Pattern
The Samrat Pharmachem Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Samrat Pharmachem Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Samrat Pharmachem Ltd (NSE: , BSE: 530125) operates in the Process industries sector and Chemicals: specialty industry. Monitoring the Samrat Pharmachem Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Samrat Pharmachem Ltd Shareholding Pattern (Latest)
The latest Samrat Pharmachem Ltd shareholding for Dec 2025 is:
- Promoters: 49.09%
- FII: 0%
- DII: 0%
- Public: 50.91%
- Government: 0%
Promoter holding in Samrat Pharmachem Ltd remains stable, reflecting consistent long-term commitment.
Samrat Pharmachem Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Samrat Pharmachem Ltd.
- Dec 2025: 49.09%
- Sept 2025: 49.09%
- Jun 2025: 49.09%
- Mar 2025: 49.09%
- Dec 2024: 49.09%
Promoter stake remains largely stable, showing consistent ownership structure.
Samrat Pharmachem Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Samrat Pharmachem Ltd.
- Dec 2025: 0%
- Sept 2025: 0%
- Jun 2025: 0%
- Mar 2025: 0%
- Dec 2024: 0%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Samrat Pharmachem Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Dec 2025: 0%
- Sept 2025: 0%
- Jun 2025: 3.24%
- Mar 2025: 0%
- Dec 2024: 0%
DII holdings remain stable, reflecting steady institutional participation.
Samrat Pharmachem Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Dec 2025: 50.91%
- Sept 2025: 50.91%
- Jun 2025: 47.67%
- Mar 2025: 50.91%
- Dec 2024: 50.91%
Public holding remains stable with consistent retail participation.
Samrat Pharmachem Ltd Government Holding
Government holding in Samrat Pharmachem Ltd currently stands at 0%.
Samrat Pharmachem Ltd operates without significant government ownership.
Samrat Pharmachem Ltd Shareholding Analysis Summary
The Samrat Pharmachem Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Samrat Pharmachem Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Samrat Pharmachem Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800